$1.3m Biomedical Catalyst Grant Awarded for Neurodegeneration Studies

Chronos Therapeutics has been awarded $1.3m grant for new work on neurodegeneration by the UK Innovation Agency the Technology Strategy Board.

Contact Us

Want to get in touch? Send us an email.

Not readable? Change text. captcha txt